Global Anticoagulant Reversal Drugs Market size to reach USD 1.6 Billion by 2027 - KBV Research

NEW YORK - July 7, 2021 - PRLog -- According to a new report Global Anticoagulant Reversal Drugs Market, published by KBV research, The Global Anticoagulant Reversal Drugs Market size is expected to reach $1.6 billion by 2027, rising at a market growth of 13.3% CAGR during the forecast period.

The andexanet alfa segment would exhibit promising CAGR over the forecast period owing to the increasing approval and launch of andexanet alfa in the major markets. The Centers for Medicare & Medicaid Services (CMS) in April 2020 established a J-code for Andexxa, thereby streamlining its reimbursement policies in the hospital outpatient settings. Therefore, supportive reimbursement policies for andexanet alfa in key markets would drive the segment growth throughout the forecast period.

The global anticoagulant reversal drugs market was dominated by Hospital pharmacy segment in 2020. As hospitals are the main centers where diagnosis and treatment of various types of bleeding disorders are performed, thus this segment is expected to grow significantly over the forecast period. Unstoppable bleeding due to blood-related disorders during emergency conditions will further drive the growth of the segment.

Full Report:

Global Anticoagulant Reversal Drugs Market Segmentation

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Product Type
  • Idarucizumab
  • Andexanet Alfa
  • Prothrombin Complex Concentrates
  • Phytonadione
  • Protamine
  • Others

By Geography

North America
  • US
  • Canada
  • Mexico
  • Rest of North America

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • Boehringer Ingelheim International GmbH
  • CSL Limited
  • Bausch Health Companies, Inc.
  • Octapharma AG
  • Pfizer, Inc.
  • Fresenius SE & Co. KGaA
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • Reddy's Laboratories Ltd.
  • AMAG Pharmaceuticals, Inc. (Covis Pharma)
  • Alps Pharmaceutical Ind. Co., Ltd.

KBV Research
+1 (646) 661-6066
Posted By:*** Email Verified
Tags:Market Research
Location:New York City - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
KBV Research PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share